BPC-157 10mg + TB-500 10mg Wolverine Stack

BPC-157 10mg + TB-500 10mg Wolverine Stack Overview

The BPC-157 10mg + TB-500 10mg Wolverine Stack is a combined research preparation containing two synthetic research peptides within a single vial.

The preparation contains 10mg BPC-157 and 10mg TB-500, providing a total nominal peptide content of 20mg.

BPC-157 is a synthetic pentadecapeptide consisting of 15 amino-acid residues. It has been investigated primarily within preclinical research involving cellular signalling, angiogenesis-associated pathways and experimental tissue models.

TB-500 is a synthetic peptide preparation associated with thymosin beta-4 research. Experimental literature surrounding this area includes investigations involving actin regulation, cellular migration and tissue-response pathways.

The term “Wolverine Stack” is an informal name commonly used for the BPC-157 and TB-500 combination. It is not a scientific or medical classification.

Interlink Peptides supplies this combined preparation strictly for laboratory and scientific research applications.

Technical Specification

Product: BPC-157 + TB-500 Wolverine Stack
BPC-157 content: 10mg
TB-500 content: 10mg
Total nominal peptide content: 20mg
Quantity: 1 × combined vial
Form: Lyophilised powder
BPC-157 peptide length: 15 amino acids
Storage: −20 °C in lyophilised form
After reconstitution: Store refrigerated at 2–8 °C
Certificate of Analysis: Available where applicable

Exact identity, composition and analytical specifications should be confirmed using documentation applicable to the relevant batch.

Research Background

BPC-157 and TB-500 are distinct research peptides and should not be considered the same compound simply because they are combined within this preparation.

BPC-157 has been investigated extensively in preclinical experimental models. Published research includes studies examining cellular signalling, angiogenesis-associated pathways and responses within various experimental tissue models.

TB-500 is associated with research surrounding thymosin beta-4-related peptide activity. Thymosin beta-4 research includes investigations involving actin dynamics, cellular migration and other cellular processes.

Combining the two compounds within a single research preparation enables both peptides to be present within the same experimental material while retaining their distinct molecular identities.

The available evidence surrounding these compounds is predominantly preclinical. Findings from laboratory or animal research should not automatically be interpreted as demonstrating effects in humans.

Interlink Peptides makes no claims regarding injury recovery, tendon or muscle repair, wound healing or other therapeutic effects.

Handling & Storage

Store the combined BPC-157 and TB-500 preparation in its lyophilised form at approximately −20 °C, protected from light and moisture.

Once reconstituted with water, store refrigerated at approximately 2–8 °C.

Allow the sealed vial to reach an appropriate laboratory working temperature before opening to minimise condensation inside the vial.

Avoid unnecessary repeated freeze-thaw cycles. Preparation, solvent selection and experimental handling should be determined according to the receiving laboratory’s validated procedures.

Quality & Testing

Certificate of Analysis documentation is available where applicable.

Identity, purity, composition and other analytical specifications should be confirmed against documentation associated with the relevant batch.

Explore our full range of research peptides for laboratory and scientific research applications.

The individual BPC-157 10mg and TB-500 10mg research products are also available separately.

Frequently Asked Questions

What is the Wolverine Stack?

“Wolverine Stack” is an informal name commonly used to describe a research combination containing BPC-157 and TB-500. It is not a recognised scientific or medical classification.

How much BPC-157 and TB-500 does this vial contain?

The combined vial contains 10mg BPC-157 and 10mg TB-500, giving a total nominal peptide content of 20mg.

Are BPC-157 and TB-500 the same peptide?

No. They are distinct research compounds with different molecular structures and areas of experimental investigation.

Are the two compounds supplied separately?

Not in this particular product. This presentation contains BPC-157 and TB-500 together within a single combined vial. Separate BPC-157 10mg and TB-500 10mg products are also available within our research range.

Is a Certificate of Analysis available?

Certificate of Analysis documentation is available where applicable. Exact analytical specifications should be checked against documentation relating to the relevant batch.

How should the Wolverine Stack be stored?

Store the lyophilised preparation at −20 °C, protected from light and moisture. Once reconstituted with water, store refrigerated at 2–8 °C.

Research Use Only

Interlink Peptides supplies BPC-157 10mg + TB-500 10mg Wolverine Stack strictly for in-vitro laboratory and scientific research purposes.

This product is not intended for human or animal consumption, medical treatment, therapeutic use or clinical application.

We do not provide dosing or administration guidance. Purchasers are responsible for ensuring that their intended use complies with applicable laws and institutional requirements.